Novel thrombospondin-1 transcript exhibits distinctive expression and activity in thyroid tumorigenesis

Area of Science:

• Molecular Biology
• Cancer Research
• Biochemistry

Background:

• Thrombospondin 1 (TSP1) plays a role in cancer progression, with potential for alternative splicing.
• Thyroid cancer exhibits complex molecular mechanisms influencing tumor development.

Purpose of the Study:

• To identify and characterize novel TSP1 splice variants in thyroid cancer.
• To investigate the functional role of TSP1V in thyroid tumorigenesis.
• To explore modulators of TSP1V expression and its diagnostic potential.

Main Methods:

• Identification of TSP1V using reverse transcription polymerase chain reaction (RT-PCR) and minigene assays.
• In vitro and in vivo experiments to assess TSP1V's anti-tumorigenic activity.
• Analysis of signaling pathways (phospho-Smad, phospho-focal adhesion kinase) affected by TSP1V.
• Investigation of phytochemicals, NSAIDs, RBM5, and trans-chalcone on intron retention (IR) and TSP1V expression.

Main Results:

• TSP1V, a novel TSP1 splice variant generated by intron retention (IR), was identified in human thyroid cancer.
• TSP1V exhibited anti-tumorigenic properties in vitro and in vivo, contrasting with wild-type TSP1.
• TSP1V inhibited phospho-Smad and phospho-focal adhesion kinase signaling.
• Phytochemicals and NSAIDs enhanced IR; RBM5 suppressed sulindac sulfide-induced IR.
• Trans-chalcone demethylated TSP1V, blocking MBD2 binding.
• Lower TSP1V levels correlated with differentiated thyroid carcinoma.

Conclusions:

• TSP1V is a tumor-suppressive splice variant of TSP1 in thyroid cancer.
• Modulation of IR by compounds and proteins affects TSP1V levels and function.
• TSP1V holds potential as a diagnostic biomarker for thyroid tumor progression.